-
CCT007093: Reading the PPM1D–p38 Circuit
2026-08-25
CCT007093 is a PPM1D inhibitor that reveals how phosphatase control shapes p38 signaling and cell fate. This article connects biochemical target engagement with cancer and kidney injury assays while emphasizing timing, controls, and interpretation.
-
Restoring PTEN with Modified mRNA in Resistance Models
2026-08-25
A translational framework for using EZ Cap™ Human PTEN mRNA (ψUTP) to investigate PTEN restoration, PI3K/Akt signaling, and therapy resistance while balancing delivery, immune response, and experimental reproducibility.
-
DFCP1 Regulates ATGL Lipolysis During Starvation
2026-08-24
The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of starvation-induced lipid droplet catabolism. Its central mechanistic finding is that DFCP1 recruits ATGL to lipid droplets but restricts ATGL turnover on their surface, thereby slowing lipolysis and refining current models of lipid mobilization.
-
EdU Imaging for Fibrosis Translational Research
2026-08-24
Pulmonary fibroblast proliferation is a mechanistic link between environmental exposure and tissue remodeling. This thought-leadership article explains how EdU-based S-phase measurement can strengthen polystyrene nanoplastic fibrosis models, complement iron-homeostasis findings, and improve translational decision-making without overstating what proliferation alone can prove.
-
Sex Differences in Angiotensin II Hypertension
2026-08-23
Xue, Pamidimukkala, and Hay used telemetry, gonadectomy, baroreflex testing, and ganglionic blockade to define sex-dependent responses to chronic angiotensin II in conscious mice. Male mice developed substantially greater hypertension and showed stronger autonomic dependence, whereas female mice were relatively protected, providing a mechanistic framework for sex-aware hypertension research.
-
Hexamethonium Bromide in Autonomic Research
2026-08-22
Hexamethonium Bromide enables reversible interrogation of ganglionic nicotinic signaling in neuronal, autonomic, and hypertension workflows. Its greatest value is as a mechanistic bridge between telemetry phenotyping and cholinergic neurotransmission inhibition, especially when sex-specific cardiovascular responses are being investigated.
-
AZD1480: A Practical JAK2 Inhibitor Workflow
2026-08-22
AZD1480 combines subnanomolar biochemical potency with a practical workflow for separating tumor-intrinsic JAK2/STAT3 signaling from immune-microenvironment effects. This guide covers formulation, phosphoprotein validation, myeloma and solid-tumor assays, combination studies, and troubleshooting for more reproducible results.
-
Mechanisms of Cell Death in Heart Disease
2026-08-21
The reference review reframes cardiac injury by showing that necrosis, like apoptosis, can be actively regulated rather than being purely passive. Its synthesis connects death-receptor, mitochondrial, endoplasmic-reticulum, and energy-failure pathways, providing a framework for interpreting myocardial infarction and heart failure mechanisms and for evaluating pharmacological interventions.
-
Calpeptin: Calpain Inhibitor Research Guide
2026-08-20
Calpeptin is a calpain inhibitor with an IC50 of 5 nM for human calpain 1. Its reported activity in lung fibroblasts and bleomycin-induced mouse pulmonary fibrosis models supports its use as a research tool for fibrosis and inflammation modulation, not as a clinical treatment.
-
Self-Amplifying RNA Vaccines for Influenza: Study Insights
2026-08-20
This study compares nucleoside-modified mRNA, self-amplifying RNA, and circular RNA vaccine strategies for seasonal influenza, with particular attention to the persistent weakness of mRNA responses against influenza B. Its central finding is that a low-dose trivalent self-amplifying RNA formulation produced durable antibody responses and complete protection in mice against influenza B challenge, supporting platform selection as a dose-sparing strategy.
-
Reversible Cell-Surface Labeling for Translational Insight
2026-08-19
Sulfo-NHS-SS-Biotin connects selective cell-surface chemistry with emerging biology around glycoRNA–RNA-binding protein domains. This thought-leadership guide shows how reversible labeling can strengthen mechanistic validation, purification, and translational decision-making without overstating what the assay can prove.
-
M-CSF as a Translational Lever in Macrophage Biology
2026-08-19
Macrophage state is not a fixed variable: it is shaped by survival cues, differentiation signals, metabolic programs, and tissue context. This thought-leadership guide connects Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) to the IGF2BP1–THBS1–TLR4 axis reported in pulmonary fibrosis, translating mechanistic insight into practical assay design, product selection, and translational strategy.
-
DOTAP for Mitochondrial Gene Delivery Design
2026-08-18
Discover how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) can support assay design for nucleic acid delivery, with a focused analysis of mitochondrial rescue strategies in glaucoma research. This guide separates evidence from formulation hypotheses and translates a 2026 microneedle study into practical workflow decisions.
-
MOG (35-55): From EAE Induction to Translation
2026-08-18
MOG (35-55) is more than an established EAE inducer: it is a defined antigenic entry point for connecting autoimmune priming with interferon signaling, neuroinflammation, and therapeutic response. This article outlines how translational researchers can use the peptide to build more reproducible, mechanism-aware multiple sclerosis research programs.
-
Angiotensin 1/2 (2-7): Assay Design Guide
2026-08-17
Explore how the Angiotensin 1/2 (2-7) peptide supports RAS and blood pressure regulation research. This guide connects sequence-aware assay design with emerging evidence on angiotensin peptide interactions with SARS-CoV-2 spike receptors.